INCYTE
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.
INCYTE
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1991-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.incyte.com
Total Employee:
501+
Status:
Active
Contact:
855-463-3463
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Brizzey
Brizzey is a firm of seasoned professionals, which guides and supports companies in planning, production, global distribution.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Promiliad Biopharma
Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-09 | ARIAD Pharmaceuticals - European operations | ARIAD Pharmaceuticals - European operations acquired by Incyte | 275 M USD |
| 2003-02-18 | Maxia Pharmaceuticals | Maxia Pharmaceuticals acquired by Incyte | N/A |
| 2000-12-01 | Proteome | Proteome acquired by Incyte | N/A |
| 1998-01-22 | Synteni | Synteni acquired by Incyte | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-02-14 | Agenus | Incyte investment in Post-IPO Equity - Agenus | 60 M USD |
| 2002-03-27 | Iconix Biosciences | Incyte investment in Venture Round - Iconix Biosciences | 20 M USD |
| 2001-07-26 | De Novo Pharmaceuticals | Incyte investment in Series B - De Novo Pharmaceuticals | 16.75 M GBP |
| 2000-06-26 | GeneEd | Incyte investment in Seed Round - GeneEd | 2 M USD |
Official Site Inspections
http://www.incyte.com Semrush global rank: 494.63 K Semrush visits lastest month: 101.15 K
- Host name: 20.119.8.32
- IP address: 20.119.8.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
